To further investigate the impact of CD73 on TME, we established tumor xenografts using B16-F10 cells, and respectively treated them with PBS or APCP, a small molecule inhibitor targeting CD73 (Figures 6A–C). This evidence concerns the gene NT5E and neoplasm.